Double Your Impact for the Holidays
Double Your Impact for the Holidays
Your urgently needed year-end gift can go twice as far to provide care and support and accelerate Alzheimer's research this holiday season — and all year long. Show your giving spirit today during this 2x Match Challenge.
Donate NowLocal experts react to FDA approval of blood test biomarker for early Alzheimer’s detection
In May, the FDA approved another biomarker to help millions of patients and families affected by Alzheimer’s disease: a blood test that detects amyloid plaques, a hallmark of the disease.
WPXI-TV spoke with those fighting for a cure here in the Pittsburgh area. Sara Murphy, vice president for programs and services for the Greater Pennsylvania chapter of the Alzheimer’s Association, said while there’s still work to be done, this FDA clearance is a huge step for early detection.
Full Story: https://www.wpxi.com/news/local/local-experts-react-fda-approval-blood-test-biomarker-early-alzheimers-detection/ZGPJH4CVJVFWPD6NPVK2MMVBAU/